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Estrogen receptors (ERs) are a group of proteins activated by 17β-estradiol. The endocrine-disrupting chemi-
cals (EDCs) mimic estrogen action by bind directly to the ligand binding domain of ER. From this perspective,
ER represent a good model for identifying and assessing the health risk of potential EDCs. This ability is
best reflected by the ligand-ER binding energy. Multilayer fragment molecular orbital (MFMO) calculations
were performed which allowed us to obtain the binding energy using a calculation scheme that considers the
molecular interactions that occur on the following model systems: the bound and free receptor, 17β-estradiol
and a water cluster. The bound and free receptor and 17β-estradiol were surrounded by a water shell contain-
ing the same number of molecules as the water cluster. The structures required for MFMO calculations were
obtained from molecular dynamics simulations and cluster analysis. Attractive dispersion interactions were
observed between 17β-estradiol and the binding site hydrophobic residues. In addition, strong electrostatic
interactions were found between 17β-estradiol and the following charged/polarized residues: Glu 353, His 524
and Arg 394. The FMO2-RHF/STO-3G:MP2/6-31G(d) weighted binding energy was of -67.2 kcal/mol. We
hope that the model developed in this study can be useful for identifying and assessing the health risk of
potential EDCs.
I. INTRODUCTION
The chemical industry is introducing around 700 syn-
thetic compounds on the market every year1. These
chemicals come on top of the 85000 substances listed in
the EPA’s chemical inventory. These compounds have a
very wide range of applications and humans will come in
contact to most of them through various routes. They
may take a long time to degrade into harmless products.
Some may not break down and persist in the environ-
ment. A large number of synthetic chemicals have been
shown to damage wildlife populations, and pose large-
scale hazards to human health2. Despite their negative
effects, humanity is increasingly dependent on synthetic
chemicals. According to the UN, output will grow seven
times faster than the global population between 1990 and
20303. This chemical explosion is perhaps one of the most
formidable challenges confronting mankind today4,5.
Nuclear receptors (NRs) are evolutionary conserved
intracellular proteins responsible for transmitting exter-
nal signals to the cell nucleus. Most of these proteins
act as ligand-inducible transcription factors and respond
to endogenous (endobiotics) and exogenous (xenobiotics)
chemicals in order to regulate gene expression. NRs af-
fect a variety of biological functions, such as reproductive
development or detoxification of foreign substances and
fatty acid metabolism. NRs mediate chemical communi-
cation between different organs via the endocrine system,
but also the interaction between organisms and their en-
vironment. They act as xenosensors and endocrine regu-
lators, which connect and integrate endogenous hormone-
regulated functions with external dietary and/or environ-
mental stimuli6.
a)Electronic mail: rugarte@uach.cl
Figure 1. Chemical structure of 17β-estradiol (C18H24O2)
The endocrine system is sensitive to stimulations
by low concentrations of hormones. Chemicals act-
ing as endocrine-disrupting chemicals (EDCs)7, either
natural or synthetic, alters the hormonal and homeo-
static systems that enable the organism to communi-
cate with and respond to its environment. EDCs af-
fect the endocrine system by mimicking natural hor-
mones, antagonizing their action or modifying their
synthesis, metabolism and transport. A large num-
ber of industrial chemicals have polycyclic aromatic
structures which confer them the ability to bind
NRs involved in steroid hormone metabolism. These
EDCs include synthetic chemicals used as industrial
solvents/lubricants and their byproducts (polychlori-
nated biphenyls, polybrominated biphenyls, dioxins),
plastics (bisphenol A), plasticizers (phthalates), pes-
ticides (methoxychlor, dichlorodiphenyltrichloroethane
or DDT), fungicides (vinclozolin), and pharmaceutical
agents (diethylstilbestrol). Natural chemicals found in
human and animal food chains (e.g., phytoestrogens, in-
cluding genistein and coumestrol) can also act as en-
docrine disruptors8.
A large range of xenobiotics have been found to bind
and activate estrogen receptors (ERs), a group of pro-
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2teins activated by the sex steroid hormone 17β-estradiol
(E2) (Figure 1). Two subtypes of ER exist: ERα and
ERβ, which are members of the nuclear receptors su-
perfamily. Both ER subtypes possess a modular organi-
zation that is characteristic of the NRs; five functional
domains from the N- to C-termini, designated A/B, C
(DNA-binding domain, DBD), D, E (ligand-binding do-
main, LBD), and F9,10. Numerous crystal structures
have been determined for the LBDs of both subtypes,
and these have given a detailed insight into the structure
and alterations during the ligand binding. The structure
of ER LBD reveals a conserved core of twelve α-helices
and a short two-stranded antiparallel β-sheet arranged
into a three-layered sandwich fold; this arrangement gen-
erates a mostly hydrophobic cavity in the lower part of
the domain which can accommodate the ligand6 (Figure
2). Since different classes of compounds might bind to
ER LBD and elicit hormone-like effects in humans, ER
represent a good model system for identifying and as-
sessing the health risk of potential EDCs. This ability is
best reflected by the ligand-ER binding energy. A num-
ber of experimental and theoretical studies have been
performed to investigate the ligand-ER interaction11−34,
and since 1997 about 100 crystal structures of ER LBD
with several ligands have been solved and deposited in
the Research Collaboratory for Structural Bioinformatics
(RCSB) Protein Data Bank (PDB). On the basis of the
above information, the mode of binding between ERs and
their ligands has been determined. The specific recogni-
tion between ER and its ligand mainly depends on hy-
drogen bonds and hydrophobic contacts35,36.
Most of the theoretical studies which use the structures
deposited in RCSB PDB are carried out using molecu-
lar dynamics (MD) simulations. These simulations are
based on empirical force fields that may not be accurate
enough to predict ligand-ER binding energies. Accuracy
requirements could be provided by ab initio quantum
mechanical calculations, but these can be very compu-
tationally expensive and time consuming. The hybrid
QM/MM (quantum mechanics/molecular mechanics) is
a method that combines the precision of quantum me-
chanics and the speed of empirical force fields. In this
approach, part of the system that includes the chemically
relevant region is treated quantum mechanically (QM)
while the remainder, often referred to as the environ-
ment, is treated at the classical level using empirical or
molecular mechanics (MM) force fields. This multiscale
approach reduces the computational cost significantly as
compared to a QM treatment of the entire system and
makes simulations possible38,39. An efficient alternative
to either the full ab initio QM, MM or QM/MM, lies in
the fragment-based methods, which form an actively de-
veloped field of research40. Fragment Molecular Orbital
(FMO) method41,42 is one such method that has been
used for efficient and accurate QM calculations in very
large molecular systems21,43. FMO involve fragmenta-
tion of the chemical system, and from ab initio or den-
sity functional quantum-mechanical calculations of each
Figure 2. Model of ERα LBD (ribbon) complexed with EST
(ball and stick)37. The model based on the RSCB PDB crystal
structure (PDB code 1A52) includes 258 amino acid residues.
fragments (monomers) and their dimers (and trimers if
greater accuracy is required) one can construct the total
properties. The distinctive feature of FMO is the inclu-
sion of the electrostatic field from the whole system in
each individual fragment calculation, and in using the
systematic many-body expansion. The FMO method is
suited to various analyses, as it provides information on
fragments and their interactions that are naturally built
into the method.
In the present article, we report a study on an ap-
proximate calculation of the binding energy between 17β-
estradiol and LBD of human estrogen receptor alpha in
aqueous medium. Briefly, the main steps of the calcula-
tion are as follows: 1) Search for representative structures
of the conformational space around the crystallographic
state of E2-ERα LBD by means of MD simulations and
cluster analysis; 2) Geometry optimization of the repre-
sentative structures using QM/MM approach; 3) Single
point FMO calculation on the optimized structures in
order to obtain the inter-fragment interaction energies.
In general, the same steps were applied to other related
model systems (vide infra).
II. METHODS
A. Model Building
Crystal structure of the ERα LBD in complex with
E2 (PDB code 1A52) were downloaded from the RSCB
PDB44. The model was constructed from chain A of the
homodimer. Atomic coordinates for missing amino acid
3residues (297-305, 545-554), missing heavy atoms and hy-
drogen atoms, were reconstructed with the LEaP mod-
ule of AmberTools 15 package45. AMBER FF14SB force
field was selected for the proteins and general AMBER
force field (GAFF) parameters46 were employed for E2.
In order to parameterize E2, electrostatic potential was
calculated by Gaussian 09 program at the HF/6-31G(d)
level of theory47. Partial charges were fitted by RESP
method of the Antechamber module of AmberTools 1548.
Arg, Lys, Asp, Glu residues were modeled as charged
species, all tyrosines as neutral, and histidine residues
were modeled according to information obtained from
another source22. Three of the 13 residues of histidine,
were protonated in order to preserve the electroneutral-
ity of the system. The N- and C-terminus residues were
protonated and deprotonated, respectively. The model
was solvated with TIP3P water in a pre-equilibrated box
measuring 111 x 100 x 62 A˚3. The E2-ER-W system con-
tains 258 amino acid residues (4190 atoms), E2 and 19979
water molecules (W). The total number of atoms in the
system is 64171. E2-ER-W was subjected to three suc-
cessive steps of minimization using the SANDER module
of the AmberTools 15. First, 1000 steps of steepest de-
scent followed of 1500 steps of conjugate gradient, allow-
ing only H atoms and water to move while holding the
rest of the system fixed. Next, the same minimization
algorithm is used as the previous one, but allowing only
E2-ER-W to move. Finally, the whole system was min-
imized without any restraints for 2000 steps of steepest
descent followed by 1000 steps of conjugate gradient.
B. Molecular Dynamics Simulations
All simulations were carried out with the SANDER
module of the AmberTools 15 with periodic boundary
conditions, using Particle Mesh Ewald method49 to treat
long-range electrostatics interactions with a non-bonded
cutoff of 12 A˚. All bonds involving hydrogen atoms were
restrained using the SHAKE50 algorithm. Temperature
regulation was done using a Langevin thermostat with
collision frequency of 1 ps−1. The Berendsen barostat
was used for constant pressure simulation at 1 atm, with
a relaxation time of 1 ps. The time step was 1 or 2
fs. The final energy-minimized system (E2-ER-W) was
then submitted to the following protocol:
Scheme 1: [0→310 K: 100 ps 1 fs NVT]−→[310 K:
500 ps 2 fs NPT]−→[310→5 K: 100 ps 1 fs NVT]
From the restart file of the last simulation in Scheme
1, we conducted an extensive set of molecular dynamics
simulations to explore the conformational space in the
vicinity of the crystallographic structure. To circumvent
the limited conformational sampling ability of MD simu-
lations at 310 K, we used multiple-trajectory short-time
simulations51. By combining the sampling ability of
the multiple trajectories, we expect to sample more
conformational space than single trajectory of the same
length. The aforementioned restart file was used as seed
for 30 short-time simulations that obey the protocol
established in Scheme 2:
Scheme 2: [5→150 K: 30 ps 1 fs NVT]−→[150→310 K:
70 ps 1 fs NPT]−→[310 K: 500 ps 1 fs NVE]
The initial velocities (Scheme 2) were assigned ran-
domly from a Maxwell-Boltzmann distribution at 5 K.
The trajectories start with the same structure and differ
only in the initial velocity assignment. At the end of the
equilibration, from ∼ 40 ps NPT ensemble, the average
temperature of the final 30 ps was 310 K, and the average
density was 1.0 g/ml. All production runs of 0.5 ns were
performed in an NVE ensemble at 310 K.
C. Cluster Analysis
Cluster analysis methods have been developed for an-
alyzing simulation trajectories of biomacromolecules and
used for the analysis of their conformational behavior
in solution52,53. These methods group together similar
conformers from molecular simulations. A clustering ap-
proach based on the Cα-RMSD (root mean square devia-
tion) was applied to the snapshots of the MD simulations.
We selected the alpha carbon atoms because they de-
scribe the backbone conformations. The Cα-RMSD was
calculated after rigid body alignment of Cα atoms of each
frame of the trajectory with respect to Cα atoms of the
average structure of the protein. Prior to clustering, the
individual E2-ER-W trajectories from the 30 short-time
simulations were combined into a single file and the wa-
ter molecules removed. In our analysis, 15000 snapshots
were grouped into five clusters. Each cluster is described
by a centroid structure, which in itself is not physically
significant as it is effectively a mathematical construct
based on the members of a cluster. However, the ac-
tual structure closest to the centroid (rmsd) is significant
and representative of each cluster. Therefore, each of
these structures corresponds to snapshots of the MD tra-
jectory. Thus, five representative structures (E2-ER) of
each cluster, and therefore of the conformers population,
were obtained54. Finally, from E2-ER we return to the
corresponding E2-ER-W representative structures.
D. QM/MM Optimization
All E2-ER-W systems representative of the population
were subjected to geometry optimization using Gaus-
sian 09 at the MM/Amber level of theory. Then, to fa-
cilitate the QM/MM calculations, the water molecules
beyond 10 A˚ of the protein surface were deleted us-
ing VMD program55. As a consequence, new model
systems (E2-ER-w) with a water layer of 10 A˚ around
of receptor surface were generated. ONIOM,38 a hy-
4Figure 3. FMO2 calculation model: ∆EBinding =
[
∆EE2−ER−wInteraction + ∆E
w
Interaction
]
−
[
∆EER−wInteraction + ∆E
E2−w
Interaction
]
brid QM/MM method implemented in Gaussian 09, with
electronic embedding was used for the geometry opti-
mization of E2-ER-w model systems. Electronic embed-
ding procedure best describes the electrostatic interac-
tion between the QM (E2) and MM (ER-w) regions,
because it includes the partial charges of the MM re-
gion into the quantum mechanical Hamiltonian. In this
way, the wave function of the QM region can be polar-
ized. In the present study we used a two-layer ONIOM
(B3LYP/6-31+G(d):AMBER) scheme: E2 (B3LYP/6-
31+G(d)); ER-w(AMBER).
E. Related Model Systems
In order to calculate the binding energy we also re-
quire ER-w, E2-w and water (w) model systems (Figure
3). ER-w and E2-w are derived, respectively, of MD sim-
ulations of ER-W and E2-W systems. Practically the
same protocol described in the methods section was re-
quired to obtain five representative ER-w structures and
two representative E2-w structures. In addition, by re-
moving 17β-estradiol from E2-ER-w and E2-w followed
by optimizing the geometries of the resulting systems at
the appropriate level of theory, five new ER-w and two
w model systems were obtained.
F. FMO Calculations
Fragment-based approaches allude to the chemical idea
of parts of the system retaining their identity to a large
extent (e.g., functional groups and residues). FMO
method not only reduces the computational cost, but
it also provides a wealth of information on the proper-
ties of fragments and their interactions. In this study,
the calculation of the binding energy is based on ob-
taining the following interaction energies between pair
of fragments: E2-amino acid residue (est-aa), E2-water
(est-wat), amino acid residue-amino acid residue (aa-aa),
amino acid residue-water (aa-wat) and water-water (wat-
wat). These pair interaction energies (PIEs) will be com-
puted in the following model systems: ER-w, E2-w, E2-
ER-w and w (Figure 3).
The energy expression in the two-body FMO expansion
(FMO2) is41:
E =
N∑
I
EI +
N∑
I>J
(EIJ − EI − EJ) (1)
The total energy E of the system is written as the sum
of the monomer energies EI , and the pair interaction en-
ergies (EIJ −EI −EJ = ∆EIJ), where EIJ is the energy
of the dimer made of two fragments I and J . The order
of the fragments in the FMO input file is very important:
water → ER amino acid residues → 17β-estradiol. Let
A = number of water fragments, B = number of water
+ amino acid residue fragments and C = total number
of fragments (water + amino acid residue + E2). Ac-
cording to the above schema and the FMO2 calculation
model (Figure 3):
∆EBinding = [E
E2−ER−w+Ew]−[EER−w+EE2−w] (2)
EE2−ER−w =
N=C∑
I=1
EI +
N=C∑
J=1 I>J
∆EIJ (3)
Ew =
N=A∑
I=1
EI +
N=A∑
J=1 I>J
∆EIJ (4)
EER−w =
N=B∑
I=1
EI +
N=B∑
J=1 I>J
∆EIJ (5)
5Table I. Number of fragments in the model systems
Fragments ER-w E2-w E2-ER-w w
17β-estradiol 1 1
Amino acid residue 257 257
Water 5153 5153 5153 5153
Total 5410 5154 5411 5153
EE2−w =
N=A∑
I=1
EI + EA+1 +
N=A∑
J=1 I>J
∆EIJ
+
N=A∑
J=1
∆E(A+1)J (6)
We assume that the monomer energies are practically
independent of the model systems and since these terms
are subtracted from each other, then:
∆EBinding =
N=C∑
J=1 I>J
∆EIJ +
N=A∑
J=1 I>J
∆EIJ
−
N=B∑
J=1 I>J
∆EIJ −
N=A∑
J=1 I>J
∆EIJ −
N=A∑
J=1
∆E(A+1)J
(7)
The right-side terms of equation (7) represent sums
of pair interaction energies (PIEs). For the purpose of
simplifying notation:
∆EBinding =
[
∆EE2−ER−wInteraction + ∆E
w
Interaction
]
−
[
∆EER−wInteraction + ∆E
E2−w
Interaction
]
(8)
From the FMO output file we obtain the values of the
terms on the right-side of the previous equation. The
AFO (adaptive frozen orbitals) scheme was used through-
out for fragmentation across peptide bonds, with the de-
fault settings for bond definitions. The fragmentation of
the model system was as follows: The first two amino
acid residues and each remaining amino acid residue of
ER, 17β-estradiol molecule, and the water molecule were
treated as a single fragment. Table I shows the number
of fragments in the different model systems.
For the binding energy (∆EBinding) calculation the
part of the system that is of particular interest corre-
sponds to the ligand and the binding site. In FMO,
one can address this by using multilayer FMO (MFMO),
when several fragments are assigned to a higher layer.
Wavefunctions and basis sets can be defined separately
for each layer. In this work we used the two-layer two-
body FMO method: FMO2-RHF/STO-3G:MP2/3-21G
and FMO2-RHF/STO-3G:MP2/6-31G(d) level of theory.
For example, the latter means the two-layer two-body
FMO method with layer 1 (environment) described by
RHF and the STO-3G basis set, and layer 2 (E2 and
binding site) described by MP2 and the 6-31G(d) basis
set56.
The binding site consists of all residues that have at
least one atom within 3.5 A˚ from any 17β-estradiol atom
in E2-ER-w. This generally gives a good representation
of the important residues in the binding pocket of a pro-
tein. The amino acids residues that form the binding site
of E2-ER-w and ER-w are: Leu 346, Leu 349, Ala 350,
Glu 353, Leu 384, Leu 387, Met 388, Leu 391, Arg 394,
Phe 404, Met 421, Ile 424, Leu 428, Gly 521, His 524,
Leu 525, Met 528. The binding site was constructed by
using the ArgusLab software57.
III. RESULTS AND DISCUSSION
In cluster analysis, 15000 snapshots from MD simu-
lations were processed and grouped into five (E2-ER-w,
ER-w) and two (E2-w) clusters. Thus, representative
structures (RS) of each cluster, and therefore of the con-
formers population, were obtained (Table II). The popu-
lation of each cluster is important for the calculation of
a weighted binding energy.
A. Binding energy using ER-w structures from MD
simulations of ER-W system
Table II shows the cluster population of each system
and the symbol assigned to their representative struc-
tures. Because E2 is a relatively rigid molecule, its pop-
ulation of conformers could be described by only two RS
(X, Y). In order to calculate the binding energy, all pos-
sible combinations between RS were made. For exam-
ple, AωX1X symbolizes the following calculation scheme
(Figure 3): 1 +X → A+ ωX . In this notation ωX is the
water representative structure obtained from X.
Table III shows the binding energies calculated at the
FMO2-RHF/STO-3G:MP2/3-21G level of theory. As we
can see there is a large dispersion in the binding energy
obtained with the proposed calculation scheme; the ex-
treme values are the result of the remarkable difference
of the interaction energies, ∆EE2−ER−wInteraction−∆EER−wInteraction,
between some of the RS (data not shown). The basis
of this dispersion is structural and is corroborated by
the protein backbone RMSD between pairs of superim-
posed representative structures: E2-ER-w//ER-w. The
RMSD across all 258 pairs of amino acids on the twenty
five combinations (A//1, A//2... E//5) of the RS was
measured. By averaging all these measurements, the cal-
culated RMSD mean value is 5.0 ± 1.6 A˚, a very high
value as a result of high conformational variability of the
terminal ends of the protein58. This flexibility of the ter-
minal ends has a strong impact on the aa-aa, aa-wat and
wat-wat interactions.
6Table II. Cluster Analysis of MD trajectories in the different model systems
(MS).
E2-ER-w ER-w E2-w
CP(a) 10215 3076 282 1214 213 7843 3577 2066 249 1265 5873 9127
RS(b) A B C D E 1 2 3 4 5 X Y
(a)Cluster population. (b)Representative structure of the respective clus-
ter.
Although the calculation scheme combining the rep-
resentative structures obtained through the MD simula-
tions (except for ωX or ωY which derives directly from X
or Y) seems reasonable and unbiased, it fails to calculate
the binding energy.
B. Binding energies using ER-w structures from of
E2-ER-w model system
Table IV shows the binding energies calculated
at the FMO2-RHF/STO-3G:MP2/3-21G and FMO2-
RHF/STO-3G:MP2/6-31G(d) level of theory. The bind-
ing energy calculation schema is analogous to the above.
For example, AωXaX symbolizes the following calcula-
tion scheme: a+X → A+ωX . Here, ”a” (without quotes)
stands for the representative structure derived from A by
prior elimination of 17β-estradiol.
All binding energy values are negative which, at least
at this level of calculation, would indicate a certain sta-
bility of the system; furthermore, the dispersion in the
values lie within a normal range. The RMSD mean value
obtained from the RMSD measurements on the five en-
sembles (A//a... E//e) is 0.035 ± 0.0063 A˚, which is
consistent with the dispersion observed in the binding
energy values.
The interaction energy and, therefore, the binding en-
ergy calculated by each basis set differ significantly. One
of the reasons for this basis set dependence is due to no
correction of the basis set superposition error (BSSE).
This problem that manifests mainly on smaller basis sets,
such as STO-3G and 3-21G, tends to overestimate the in-
teraction energy59.
In an FMO study of ERα LBD in complex with
17β-estradiol (PDB code 1ERE), the model system in-
cluded 241 amino acid residues, one water molecule
which directly mediates ER-E2 binding (where the hy-
drogen bonded water molecule was included in the re-
ceptor) and E2. The binding energy was estimated from:
∆EBinding = EE2−ER−(EER+EE2). The total energies
(E) were considered in the calculation and the geome-
tries of ER and E2 were fixed in those found in E2-ER
model system. The reported binding energy was -37.65
kcal/mol at FMO2-RHF/STO-3G level of theory21. In
another FMO study with the same model system, FMO2
interaction energy between E2 and ER was calculated
using HF and MP2 methods with several basis sets60.
The calculated interaction energy was -40.26 kcal/mol at
FMO2-RHF/6-31G(d) and -123.73 kcal/mol at FMO2-
Figure 4. 17β-estradiol in the binding site of ER with impor-
tant amino acid residues. Four water molecules are present,
and one of them (cylinder) links E2 and Leu 387. The fig-
ure corresponds to the A representative structure and it was
made with the ArgusLab software57.
MP2/6-31G(d) level of theory. The large interaction en-
ergy difference between the RHF and the MP2 meth-
ods is due to dispersion interaction, which can only be
described by electron correlation methods. In general,
charged and polarized amino acid residues interact ei-
ther strongly or weakly with the ligand, while hydropho-
bic residues contribute to weak interactions. The sum of
these weak dispersion interactions makes the difference
between both methods.
The interaction energies of E2 with each residue
fragment of the ER binding site at the FMO2-
RHF/STO-3G:MP2/3-21G and FMO2-RHF/STO-
3G:MP2/6-31G(d) level of theory are shown in Figure 5.
In all model systems, regardless of the calculation level,
we observe that Glu 353 and His 524 are very stable
structures. These residues present a strong electrostatic
interaction with E2, and it is known that together with
Arg 394, they form a hydrogen bond network with E2.
A water molecule is similarly responsible for yet another
stabilizing hydrogen bond between E2 and the ER
(Figure 4)22,60. Therefore, the interactions between E2
and these residues, together with the hydrogen bonds,
play a key role in the E2-ER binding.
Many binding site hydrophobic residues are stabilized
(attractive interaction) through dispersion interactions
with E2. Therefore, the MP2 electron correlation is es-
7Table III. FMO2-RHF/STO-3G:MP2/3-21G binding energy(a) (BE) of the different
combinations between the representative structures.
Model BE Model BE Model BE Model BE Model BE
AωX1X 215.5 BωX1X 179.7 CωX1X 2.1 DωX1X 381.0 EωX1X -46.1
AωY 1Y 197.3 BωY 1Y 161.5 CωY 1Y -16.1 DωY 1Y 362.8 EωY 1Y -64.3
AωX2X 126.1 BωX2X 90.3 CωX2X -87.3 DωX2X 291.6 EωX2X -135.5
AωY 2Y 107.9 BωY 2Y 72.1 CωY 2Y -105.5 DωY 2Y 273.4 EωY 2Y -153.7
AωX3X -95.3 BωX3X -131.1 CωX3X -308.7 DωX3X 70.2 EωX3X -356.9
AωY 3Y -113.5 BωY 3Y -149.3 CωY 3Y -326.9 DωY 3Y 52.0 EωY 3Y -375.1
AωX4X 59.1 BωX4X 23.3 CωX4X -154.3 DωX4X 224.6 EωX4X -202.5
AωY 4Y 40.9 BωY 4Y 5.1 CωY 4Y -172.5 DωY 4Y 206.4 EωY 4Y -220.7
AωX5X -13.6 BωX5X -49.4 CωX5X -227.0 DωX5X 151.9 EωX5X -275.2
AωY 5Y -31.8 BωY 5Y -67.6 CωY 5Y -245.2 DωY 5Y 133.7 EωY 5Y -293.4
(a)All Energies in kcal/mol.
Table IV. FMO2-RHF/STO-3G:MP2/3-21G & FMO2-RHF/STO-3G:MP2/6-31G(d) binding (BE)
and interaction energy(a) (∆Eint).
FMO2-RHF/STO-3G:MP2/3-21G
Weighted Binding Energy = -84.2
Weighted ∆Eint = -92.3
Model AωXaX AωY aY BωXbX BωY bY CωXcX CωY cY DωXdX DωY dY EωXeX EωY eY
BE -71.7 -89.9 -73.7 -91.9 -80.5 -98.7 -79.7 -97.9 -85.3 -103.5
RS(b) A B C D E
∆Eint -93.0 -88.6 -105.7 -91.3 -101.8
FMO2-RHF/STO-3G:MP2/6-31G(d)
Weighted Binding Energy = -67.2
Weighted ∆Eint = -73.6
Model AωXaX AωY aY BωXbX BωY bY CωXcX CωY cY DωXdX DωY dY EωXeX EωY eY
BE -54.6 -72.8 -57.4 -75.6 -66.9 -85.1 -62.1 -80.3 -64.0 -82.2
RS A B C D E
∆Eint -74.3 -69.6 -85.4 -74.0 -79.2
(a)Sum of all PIEs between 17β-estradiol and each amino acid residue fragment in the ER
binding site. All Energies in kcal/mol. (b)Representative structure.
sential to characterize these interactions, whose func-
tion is possibly to accommodate the substrate at the
hydrophobic binding pocket (Figure 4). Important hy-
drophobic residues at the binding site are: Leu 346, Leu
387, Leu 391, Phe 404 and Leu 52561. The behaviour
of the Arg 394 PIE (Figures 5) with respect to the rest
of the amino acid residues is remarkable. In the latter,
the behaviour is quite conservative; whereas in Arg 394
it fluctuates from -12.4 to 5.0 kcal/mol and from -7.5 to
4.6 kcal/mol, at FMO2-RHF/STO-3G:MP2/3-21G and
FMO2-RHF/STO-3G:MP2/6-31G(d) level of theory, re-
spectively. The above suggests that perhaps Arg 394
could play a stabilizing-destabilizing role in the interac-
tion between E2 and the ER binding site. According to
this hypothesis, conformational changes in the receptor
could influence the behavior of Arg 394, which would pos-
sibly determine both the entry and exit of E2 from the
binding site.
During the simulation a number of water molecules
were trapped at the binding site. Table V shows the in-
teraction energy calculated at the FMO2-RHF/STO-3G
level of theory between E2 and each water fragment in
the ER binding site. The number of water molecules
varies according to the representative structure and, at
this level of calculation, the interactions can be either at-
tractive or repulsive. It was observed that only in the rep-
resentative structure of the most populated cluster (A) a
water molecule makes a bridge between E2 and Leu 387
through the hydrogen bonds (∆Eint = -4.05 kcal/mol).
The negative value in the interaction energy of the other
structures (C, E) corresponds to an interaction by hydro-
gen bond between the 17β-OH group (D ring) of E2 and
a water molecule.
One shortcoming of this study is that we do not con-
sider the binding site as a dynamic entity, subject to
change. These, are intrinsic to the dynamics of the sys-
tem itself. The binding site is defined by the distance
between E2 and the corresponding amino acid residue,
and this distance is modified in the course of the sim-
ulation. Therefore, some residues will cease to belong
to the binding site, while others, which initially did not
belong, will become part of the binding site (Table VI).
The above is also relevant for water molecules. We hope
to address this inconsistency in a future study.
We have shown that if the structure representing the
free receptor (ER-w) differs significantly from that of the
8Figure 5. PIEs (kcal/mol) between 17β-estradiol and each amino acid residue fragment of the ER binding site for each of the
representative structures. Glu 353, Arg 394 and Hie 524 are charged/polar residues; the remaining residues are hydrophobic.
Table V. FMO2-RHF/STO-3G interaction energy(a)
(∆Eint).
RS(b) A B C D E
Water fragment 4 1 3 2 3
∆Eint -4.05 0.87 -4.01 1.38 -4.80
(a)Sum of all PIEs between E2 and each water frag-
ment in the ER binding site. (b)Representative
structure. All Energies in kcal/mol.
bound receptor (E2-ER-w), the binding energy calcula-
tions are not reliable. However, if we obtain the free
receptor from the respective bound receptor, the values
of the binding energy are less dispersed and seemingly
reliable. In this particular case, the backbone RMSD is
very small between both representative structures; that
is, the conformations are very similar. The justification
for the second calculation scheme is somewhat supported
by the conformational selection model, which postulates
that the native state of a protein does not exist as a sin-
gle, rigid conformation but rather as a ensemble of con-
formers that coexist in equilibrium with different popu-
lation distributions, and that the ligand can bind selec-
tively to the most suitable conformer. In other words,
the free protein can sample with a certain probability
the same conformation as that of the bound protein62. If
we accept the above hypothesis, it is permissible to de-
rive the free receptor from the bound receptor. Finally,
we must mention that although it is true that the repre-
sentative structures obtained from the independent MD
simulations of both systems differ significantly from each
other and, therefore, contradict one of the premises of the
conformational selection, the reason for this possibly lies
in the fact that the extension of the sampled space is in-
sufficient for the free system. Increasing conformational
sampling of the free receptor will likely allow to obtain
structures more similar to those of the bound receptor.
IV. CONCLUSIONS
The molecular interactions between 17β-estradiol and
ER were calculated, and from these the binding energy
was obtained. Two different schemes were used for the
calculation of the binding energy. In the first scheme, the
free receptor used in the calculations is obtained from MD
simulations, and the results are not reliable as the energy
values are highly dispersed. This failure is a consequence
of the lack of structural similarity between the represen-
tative structures of the free and the bound receptor. The
second scheme, which produces reliable results, uses the
structure of the free receptor obtained directly from the
bound receptor by removal of E2. The above procedure is
consistent with the conformational selection model. We
think that by increasing the conformational sampling of
the free receptor it is possible to obtain structures similar
to those of the bound receptor; indeed, if this were the
case, we could provide reasonable theoretical evidence in
favor of the conformational hypothesis.
In general, attractive dispersion interactions were ob-
served between E2 and all surrounding hydrophobic
residues. These interactions play an important role in
stabilizing E2 at the binding site. Water molecules were
found at the binding site of all representative structures;
in one of them (A), a water molecule makes a bridge
between E2 and Leu 387 through the hydrogen bonds.
Strong electrostatic interactions were observed between
the E2 and the following charged/polarized residues: Glu
9Table VI. Effect of the simulation on the amino acid residue(a) composition of the
ER binding site. The following original residues remained at the binding site: Leu
346 → Leu 525. The binding site consists of all residues that have at least one
atom within 3.5 A˚ from any E2 atom in E2-ER-w model system. (∆Eint).
RS A B C D E
Met 528(b) Met 528 Met 528
Met 343 Met 343 Met 343 Met 343
Aa residue Leu 327
Phe 425
Thr 347 Thr 347
Trp 383
(a)Charged/Polar residues are indicated by underlined characters. The remain-
ing residues are hydrophobic. (b)Original amino acid residue.
353, His 524 and Arg 394. These residues tend to be lo-
cated at the ends of E2, close to the OH groups of the
A and D rings. In particular, the behavior of Arg 394
is quite unusual since depending on its conformation or
position in the active site, the interaction with E2 can be
attractive or repulsive.
The FMO2-RHF/STO-3G:MP2/6-31G(d) weighted
binding energy was of -67.2 kcal/mol. This result clearly
suggests that 17β-estradiol and ER LBD tend to form
an enzyme-substrate complex and therefore validates our
calculation model based on interactions. We hope that
the model developed in this study can be useful for iden-
tifying and assessing the health risk of potential EDCs.
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